Historique de carrière de Jacob J. Clement
Anciens postes connus de Jacob J. Clement
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
MIGENIX, Inc.
 MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Directeur Technique/Scientifique/R&D | 31/01/2009 | 31/01/2009 |
Formation de Jacob J. Clement
| The University of North Carolina at Charlotte | Doctorate Degree |
| Roosevelt University | Graduate Degree |
| Saint Mary's University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| Canada | 3 |
Opérationnelle
| Graduate Degree | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
MIGENIX, Inc.
MIGENIX, Inc. Pharmaceuticals: MajorHealth Technology MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada. | Health Technology |
- Bourse
- Insiders
- Jacob J. Clement
- Expérience
